JP2023552002A5 - - Google Patents

Info

Publication number
JP2023552002A5
JP2023552002A5 JP2023548534A JP2023548534A JP2023552002A5 JP 2023552002 A5 JP2023552002 A5 JP 2023552002A5 JP 2023548534 A JP2023548534 A JP 2023548534A JP 2023548534 A JP2023548534 A JP 2023548534A JP 2023552002 A5 JP2023552002 A5 JP 2023552002A5
Authority
JP
Japan
Prior art keywords
group
alkyl
compound according
membered
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023548534A
Other languages
English (en)
Japanese (ja)
Other versions
JP7818011B2 (ja
JP2023552002A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/055173 external-priority patent/WO2022081967A1/en
Publication of JP2023552002A publication Critical patent/JP2023552002A/ja
Publication of JP2023552002A5 publication Critical patent/JP2023552002A5/ja
Application granted granted Critical
Publication of JP7818011B2 publication Critical patent/JP7818011B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023548534A 2020-10-16 2021-10-15 Malt1モジュレーターおよびその使用 Active JP7818011B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063092768P 2020-10-16 2020-10-16
US63/092,768 2020-10-16
PCT/US2021/055173 WO2022081967A1 (en) 2020-10-16 2021-10-15 Malt1 modulators and uses thereof

Publications (3)

Publication Number Publication Date
JP2023552002A JP2023552002A (ja) 2023-12-13
JP2023552002A5 true JP2023552002A5 (https=) 2024-09-13
JP7818011B2 JP7818011B2 (ja) 2026-02-19

Family

ID=81209361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023548534A Active JP7818011B2 (ja) 2020-10-16 2021-10-15 Malt1モジュレーターおよびその使用

Country Status (7)

Country Link
US (1) US20230391781A1 (https=)
EP (1) EP4228647A4 (https=)
JP (1) JP7818011B2 (https=)
CN (1) CN116916924B (https=)
AU (1) AU2021361057A1 (https=)
CA (1) CA3198715A1 (https=)
WO (1) WO2022081967A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202018412D0 (en) * 2020-11-23 2021-01-06 Exscientia Ltd Malt-1 modulators ii
TW202345806A (zh) 2022-03-31 2023-12-01 美商艾伯維有限公司 噻唑并〔5,4-b〕吡啶malt-1抑制劑
EP4638458A1 (en) * 2022-12-23 2025-10-29 Janssen Pharmaceutica NV Malt1 inhibitors
WO2024182599A2 (en) * 2023-03-01 2024-09-06 Rarefied Biosciences, Inc. Compositions and methods for treating malt1 associated diseases
WO2025223516A1 (zh) * 2024-04-24 2025-10-30 首药控股(北京)股份有限公司 一种抑制剂杂环化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5364620A (en) 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US4902514A (en) 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
US5593996A (en) * 1991-12-30 1997-01-14 American Cyanamid Company Triazolopyrimidine derivatives
EP1644003A1 (en) * 2003-06-04 2006-04-12 Vernalis (Cambridge) Limited Triazolo ´1,5-a!pyrimidines and their use in medicine
WO2008065198A1 (en) * 2006-12-01 2008-06-05 Galapagos N.V. Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
SG11201607895PA (en) * 2014-05-28 2016-12-29 Novartis Ag Novel pyrazolo pyrimidine derivatives and their use as malt1 inhibitors
WO2017000277A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Substituted triazolo bicycliccompounds as pde2 inhibitors
US10711036B2 (en) * 2015-08-28 2020-07-14 Cornell University MALT1 inhibitors and uses thereof
PE20190656A1 (es) * 2016-07-29 2019-05-08 Lupin Ltd Compuestos de tiazolo-piridina sustituida como inhibidores de malt1
TWI795381B (zh) * 2016-12-21 2023-03-11 比利時商健生藥品公司 作為malt1抑制劑之吡唑衍生物
EP3810609B1 (en) 2018-06-18 2024-06-12 Janssen Pharmaceutica NV Pyrazole derivatives as malt1 inhibitors
TWI848400B (zh) * 2018-11-28 2024-07-11 日商武田藥品工業股份有限公司 雜環化合物及醫藥

Similar Documents

Publication Publication Date Title
JP2023552002A5 (https=)
JP2023502441A5 (https=)
JP2019530699A5 (https=)
RU2013158933A (ru) Новые модуляторы иммунной системы родственные заявки
RU2019132666A (ru) Макроциклические соединения в качестве ингибиторов киназы ros1
PE20212304A1 (es) Inhibidores de il-17a imidazo[1,2-b]piridazin-2-il
RU2015101106A (ru) Способ лечения лимфомы, применяя тиенотриазолодиазепиновые соединения
JP2018504437A5 (https=)
RU2010105678A (ru) Гетероциклические амидные соединения как ингибиторы протеинкиназ
IL272115B (en) An aryl-phosphorus-oxygen compound as an egfr kinase inhibitor
RU2007114293A (ru) Диаминотриазольные соединения, применяемые в качестве ингибиторов протеиновой киназы
JP2010504346A5 (https=)
JP2014500870A5 (https=)
RU2018138828A (ru) Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами
RU2009105826A (ru) 2,4-ди(ариламино)питимидин-5-карбоксамидные соединения в качестве ингибиторов jak-киназ
JP2010504347A5 (https=)
JP2011046700A5 (https=)
JP2021522262A5 (https=)
RU2008122046A (ru) Аминопиримидины в качестве ингибиторов киназ
RU2014128307A (ru) Пиррольное производное шестичленного гетероарильного кольца, способ его получения и его медицинское применение
JP2022538917A5 (https=)
JP2013503139A5 (https=)
RU2013151803A (ru) Бициклические гетероциклические соединения и их применения в терапии
JP2016501185A5 (https=)
JP2023537271A5 (https=)